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Abstract Background: Precision medicine has been
adopted in a range of clinical settings where omics data have
led to greater characterisation of disease and stratification of
patients into subcategories of phenotypes and pathologies.
However, in orthopaedics, precision medicine lags behind other
disciplines such as cancer. Joint registries have now amassed a
huge body of data pertaining to implant performance which can
be broken down into performance statistics for different mate-
rial types in different cohorts of patients. The National Joint
Registry of England, Wales and Northern Ireland (NJR) is now
one of the largest datasets available. Other registries such as
those from Sweden and Australia however contain longer fol-
low-up. Together, these registries can provide a wealth of
informative for the orthopaedics community when considering
which implant to give to any particular patient. Questions/
Purposes:We aim to explore the benefits of combiningmultiple
large data streams including joint registries, published data on
osteoarthritis (OA) pathogenesis and pathology and data
concerning performance of each implant material combination
in terms of biocompatibility. We believe that this analysis will
provide a comprehensive overview of implant performance
hopefully aiding surgeons in making more informed choices
about which implant should be used in which patient.Methods:
Data from three joint registries were combined with established
literature to highlight the heterogeneity of OA disease and the
different clinical outcomes following arthroplasty with a range
of material types. Results: This review confirms that joint
registries are unable to consider differences in arthritis presen-
tation or underlying drivers of pathology. OA is now recognised
to present with varying pathology with differing morbidity in
different patient populations. Equally, just as OA is a heteroge-
neous disease, there are disparate responses to wear debris from
different material combinations used in joint replacement sur-
gery. This has been highlighted by recent high-profile scrutiny
of early failure of metal-on-metal total hip replacement (THR)
implants. Conclusions: Bringing together data from joint regis-
tries, biomarker analysis, phenotyping of OA patients and
knowledge of how different patients respond to implant debris
will lead to a truly personalised approach to treating OA pa-
tients, ensuring that the correct implant is given to the correct
patient at the correct time.
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Introduction
The increasing use of joint registry data to guide surgeons in
their choice of implant provides a huge opportunity to improve
the care that patients receive. The use of these data to identify
implants with higher failure rates, such as large bearing metal-
on-metal devices, has the potential to significantly reduce
harm to our patients. However, the temptation to extrapolate
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findings within large datasets in an effort to come up with a
single Bone size fits all^ solution must be used with caution.
Over the last few years, there has been an explosion in the use
of what is referred to as precision (or personalised) medicine in
other areas of health care. Thismodel of patient care moves away
from the one size fits all model of health care delivery and
provides personalised or precision treatment based on the indi-
vidual. For example, cancer treatment has been revolutionised by
the use of biomarkers to stratify patients into responders and non-
responders for specific pharmacological agents. This has been
particularly highlighted byAstraZeneca’s development and study
of Iressa (Gefitinib) for patients with non-small cell lung cancer.
This drug targets the epidermal growth factor receptor (EGFR)
and when administered to a large mixed cohort of patients was
shown to have poor efficacy. However, 10% of the patient cohort
had a mutation in their EGFR, and these patients responded well
to treatment [8]. This precision approach therefore improves
patient care and reduces health care costs, since those patients
who it is predicted will receive either no benefit or at worst a
detrimental effect are not administered a costly treatment regi-
men, in essence providing the right treatment to the right patient.
Within this review, we explore the use of joint registry data
in the decision making process with regards to its usefulness
and its limitations in selecting the correct bearing for our pa-
tients. We also review the evidence that suggests that osteoar-
thritis (OA) patients are a heterogeneous group and consider the
potential for biomarker analysis to provide precision medicine
which then assists the clinician in making a more informed
choice in selecting the right implant for the right patient.
Methods
Data from three large joint registries, Swedish Hip Arthroplasty
Register, National Joint Registry of England, Wales and North-
ern Ireland and the Australian Orthopaedic Association Nation-
al Joint Replacement Registry, regarding implant performance
were collated. PubMed literature searches were used to identify
articles pertaining to different presentations of OAwith regards
to environmental and demographic factors which affect OA
pathology, thus demonstrating the heterogeneity of the disease.
In order to link factors governing OA pathology with implant
failure, literature which explore the causal factors which con-
tribute to implant failure were also highlighted.
International Joint Registries
When considering joint registry data, it is difficult to ignore the
contribution from the Swedish Hip Arthroplasty Register [20].
However, the use of different bearing surfaces is relatively
limited with the large majority of hip arthroplasty utilising the
combination of metal femoral heads with a polyethylene ace-
tabulum. Over the last decade, there has been a gradual migra-
tion to the use of cross-linked or modified polyethylene. With
the most recent report, the revision rates of the cross-linked
polyethylene were found be significantly less than that of
conventional polyethylene. However, when confounding fac-
tors such as age, gender, femoral head size and acetabular
design were considered, the difference failed to reach
significance. Data for other bearings in this registry are very
limited, and therefore, it is difficult to make comparisons be-
tween multiple bearing surfaces. The 2014 report from the
National Joint Registry for England, Wales and Northern Ire-
land (NJR) [2] contained outcome data on over 620,400 hip
replacements with a maximum follow-up of 10.75 years. The
report provides a wealth of data on the outcome and usage of
hip replacements. When the registry was started in 2003,
cemented hip arthroplasty was the most common fixation mo-
dality. However, more recently, the use of uncemented hip
replacements has become more common and is now the main
method of fixation of total hip replacements (Fig. 1). The use of
hybrid fixation had remained relatively static over the years but
has increased slightly, most likely due to outcome data pub-
lished by the NJR supporting the use of hybrid fixation. The use
of different bearing combinations in cemented hip replacement
is relatively limited with 90% of the bearing articulations com-
posed of a metal femoral head and a polyethylene acetabular
component (Fig. 2). The type of bearing surface used in the
uncemented hip replacement is muchmore varied (Fig. 3).When
the registry was initiated, the two most common bearing options
were that of a metal femoral head on a polyethylene liner and the
use of a ceramic head on a polyethylene liner. Between 2003 and
present, the usage of the different bearing combinations has quite
dramatically changed. The usage of a metal-on-metal combina-
tion increased to its height in 2007 and then decreased following
this due to the concerns with respect to metal particle debris. The
use of a ceramic-on-ceramic bearings was significantly increased
in their usage to a peak in 2011. One explanation of this may
have been that ceramic-on-ceramic bearings were marketed as an
alternative to metal-on-metal bearings following the decline in
use of the latter. Ceramic femoral head on a polyethylene liner
usage decreased between 2003 and 2008 but have now gradually
increased in their usage, possibly driven by the outcome data
produced by the NJR. The use of metal on polyethylene has
remained relatively constant and in 2013 was still the most
common bearing option for uncemented hip arthroplasty. The
NJR provides a wealth of information on the cumulative proba-
bility of revision for different bearing combinations, fixation type,
age and gender. Overall, the cumulative revision rates for the
cemented group appear to show that ceramic on polyethylene
may have a slight advantage over that of metal on polyethylene
(Fig. 4). Within the uncemented group, the Kaplan-Meier esti-
mates for cumulative probability of revision show that the metal-
on-polyethylene, ceramic-on-polyethylene and ceramic-on-
ceramic combinations appear to be very tightly clustered with
the ceramic on polyethylene appearing to show a slight improve-
ment in revision rates (Fig. 5). One of the present limitations of
this registry is that the types of polyethylene are presently not
stratified by types of treatment used. This is a concern as other
registries have shown a significant advantage of the cross-linked
or modified polyethylene.
The Australian Orthopaedic Association National Joint
Replacement Registry (AOANJRR) [7] was started in 1999,
and the annual report published in 2014 contains data on
280,522 primary total hip replacements. The report provides
the percentage revision rates of an array of different bearing
surfaces. The combination of a ceramicised metal femoral
head with a cross-linked polyethylene liner has consistently
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shown the lowest revision rates (Fig. 6). The use of a metal
femoral head or a ceramic femoral head combined with a cross-
linked polyethylene liner has also shown low revision rates.
However, the combination of a ceramic-on-ceramic bearing
surface surprisingly shows a slightly higher revision rate than
that of any of the other three combinations. The AOANJRR
report clearly shows the significant reduction in revision rates
when using cross-linked polyethylene when compared to non-
cross-linked polyethylene (Fig. 7). This reduction in revision
rate appears to be explained by the reduction in revision for
loosening/lysis and a reduction in the number of revisions
performed for dislocation. The reduction in dislocation rate
would be partially explained by the increased confidence in
the use of larger head sizes with the cross-linked polyethylene.
Discussion
The wealth of information contained within the national
joint registries on the outcome of different parameters in
hip arthroplasty has the potential to drive significant change
in the way that we deliver care. However, the use of these data
to inform guidance and policy needs to be treated with caution.
This can be shown in the NJR in that the reported revision
rates over the years since the commencement of the registry
have gradually increased (Fig. 8). One may hypothesise that
this is due to the fact that more hips are being revised. How-
ever, one alternative hypothesis may be that as the registry has
become embedded into clinical practice, the robustness of the
reporting of revision operations may have improved. This
potential bias would particularly favour those implant combi-
nations that were used at the inception of the registry and
detrimental to those introduced more recently. This potential
bias would appear to potentially favour cemented fixationwith
a metal or ceramic femoral head on a polyethylene liner.
When considering how to interpret the outcomes provid-
ed by the joint registries, one key aspect that we must not
ignore is that of personalised or precision medicine. There is
significant pressure when provided with vast datasets to try
to provide a one size fits all solution. We must however be
Fig. 1. Temporal changes in percentages of each fixation method used in primary hip replacements (from the 2014 report from the National Joint
Registry for England, Wales and Northern Ireland, Figure 3.1 www.njrcentre.org.uk).
Fig. 2. Percentage changes of each bearing surface used in primary hip replacements (from the 2014 report from the National Joint Registry for
England, Wales and Northern Ireland, Figure 3.2a www.njrcentre.org.uk).
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cognisant of developments being made in other areas of
medicine. Surgeons will often personalise their choice of
implant depending on patient characteristics. An example
would be that of bone quality and the decision to use a
cemented or uncemented femoral component. Good bone
quality and a very narrow femoral canal is well suited to a
tapered uncemented stem, whereas a porotic femur with a
very large femoral canal would be more suited to a cemented
femoral component. A step further from this type of
personalised care is that of precision medicine which in-
cludes the use of biomarkers to stratify patients into different
patient groups.
Our understanding of OA and the factors which are
involved in pathogenesis has progressed beyond considering
this to be a wear and tear disease and has led to a wealth of
information pertaining to biomarkers being collected from a
multitude of patients. These patients reveal further informa-
tion regarding the prevalence of each biomarker in different
patient cohorts. Therefore, it may be prudent to marry these
data to those contained in joint registries to further stratify
patients and inform surgeons as to the correct implant for the
correct patient at the correct time.
OA Is a Heterogeneous Disease
With the majority of hip arthroplasty performed for osteoar-
thritis, it is increasingly recognised that OA is a heteroge-
neous disease [5, 13]. Multiple tissues within the joint are
now implicated in pathogenesis of OA, including not just the
cartilage but also the subchondral bone, synovium and
Fig. 3. Percentage change in bearing surface used in uncemented total hip replacement (from the 2014 report from the National Joint Registry for
England, Wales and Northern Ireland, Figure 3.2b www.njrcentre.org.uk).
Fig. 4. Cumulative probability of revision (Kaplan-Meier estimates) for cemented hips with different bearing surfaces (from the 2014 report from
the National Joint Registry for England, Wales and Northern Ireland, Figure 3.4 www.njrcentre.org.uk).
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adipose tissue, and the involvement of each of these tissues
in the pathogenesis may be dependent on the particular
patient [23]. For example, the association between increased
adiposity and OA risk has been reported to be greater in
females [11].
Critically, the heterogeneous nature of OA can also be
observed in preoperative X-ray radiographs, where the pres-
ence of osteophytes, suggesting the involvement of abnor-
mal subchondral bone remodelling, is present in some
patients but not others. Together with variations in the de-
gree of joint space narrowing, patients undergoing joint
replacement surgery vary from Kellgren Lawrence (KL)
grade 1 to KL grade 4 [12], indicating great diversity in
the radiological features of OA across patients [6].
Given that inflammation is now increasingly recognised
as a key contributor to OA joint pathology, it is significant
that MRI and histopathological studies show that the degree
of synovitis (synovial inflammation) varies between OA
patients [4]. Notably, our preliminary studies suggest that
those OA patients who are obese exhibit a more
Binflammatory^ phenotype than those patients who are of
normal weight. Indeed, inflammation associated with the
synovium and tissues adjacent to the synovium is more
prevalent in obese patients with OA, compared to normal
weight OA patients [24]. This increase in inflammation in
obese individuals can be partly attributed to our understand-
ing now that adipose tissue is an endocrine organ, capable of
releasing cytokines (termed adipokines), which can mediate
Fig. 5. Cumulative probability of revision (Kaplan-Meier estimates) for uncemented hips with different bearing surfaces (from the 2014 report
from the National Joint Registry for England, Wales and Northern Ireland, Figure 3.5 www.njrcentre.org.uk).
Fig. 6. Cumulative percent revision of primary total conventional hip replacement by type of polyethylene (primary diagnosis OA).
Figure HT24, Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip and Knee Arthroplasty Annual Report
2015. Adelaide: Australian Orthopaedic Association (AOA), 2015.
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proinflammatory and ultimately pathological effects on the
joint tissues.
The functional role of particular adipokines in OA pa-
thology is still being investigated, but current literature
suggests that the adipokines leptin, resistin and visfatin all
contribute to inflammation in the joint [14, 15, 18, 25].
Importantly however, differences in both the functional
effects in the joint and/or expression of these adipokines
in serum and in joint tissues have been reported to be
dependent on BMI and gender [18].
This evidence demonstrates that cellular activation
varies between OA patients. This naturally leads OA pre-
sentation to differ between patients giving rise to a hetero-
geneous OA phenotype. As will be discussed below,
activation of immune cells is, at least in part, responsible
for the failure of some arthroplasties in some patients.
Patients whose OA phenotype is particularly inflammatory
may, therefore, not be suited to some implant types which
are known to invoke an inflammatory response.
OA Joint Implants: One Size Does not Fit All
One particular area of concern in the arthroplasty domain
has been the skill of implantation and the familiarity of
implants to the surgeon. There is, therefore, a balance
between the personalisation of implant selection to best
suit the patient and the number of different implants that
the surgeon uses to ensure that they remain sufficiently
skilled with each device.
In the same way that OA is a heterogeneous disease with
different factors affecting disease presentation and progres-
sion, the biological response of individuals to implant ma-
terials is also diverse.
The cumulative percentage probability of first revision at
10 years is 2–4% for bearing combination such as metal or
ceramic on polyethylene and ceramic on ceramic. The ex-
ception to this is metal on metal which has a cumulative risk
percentage of 22% at 10 years [21]. This discrepancy in
longevity between metal on metal and other implants was
highlighted by Smith et al. [21]. Despite metal on metal
Fig. 7. Cumulative incidence revision diagnosis of primary total conventional hip replacement by type of polyethylene (primary diagnosis OA).
Figure HT25, Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip and Knee Arthroplasty Annual Report
2015. Adelaide: Australian Orthopaedic Association (AOA), 2015.
Fig. 8. Temporal changes in revision rates: Kaplan-Meier estimates of cumulative percentage probability of revision for each year of primary
operation (from the 2014 report from the National Joint Registry for England, Wales and Northern Ireland, Figure 3.3a www.njrcentre.org.uk).
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being predicted to be hard-wearing, there is a 50% greater
risk of metal-on-metal (MoM) failure compared to that of
metal-on-polyethylene 2 years post-surgery. The reason for
this high risk of failure is only now beginning to be under-
stood. However, such has been the fallout from the revela-
tion that MoM implants are negatively impacting on the
patients who receive them, a large body of work has been
undertaken to understand the reason for patients’ adverse
reactions to different material types at the molecular level [3,
16, 19, 22]. This work includes examination of components
of the implant such as the taper junction and acetabular cup
interface [1, 26].
One particular area of research is to examine the way in
which the patient’s immune system responds to the burden of
challenge from wear debris. Importantly, it is now accepted
that CoCrMo alloy debris elicits an immune response which
involves both macrophages and T cells [10, 17], along with an
increase in proinflammatory cytokine production [17]. Fur-
thermore, metal wear debris becomes coated in protein from
intra-tissue fluids and serum, and it is postulated that this
coating, which would include immunomodulatory proteins
such as complement, could be used by macrophages to recog-
nise and internalise non-biological materials [9].
Indeed, we have recently performed our own study to
investigate the role of the immune system in responding to
wear debris from metal-on-metal implants and the resulting
inflammatory response. Our findings show that individuals will
produce profoundly contrasting systemic biological responses
to the presence of wear debris from joint implants and that these
transcend the macrophage to implicate other lymphocytes such
as T cells [17]. Additionally, individuals will produce different
cytokine profiles in response to wear debris, and these profiles
could be used to prognostically determine the risk of using a
particular material type in any individual patient as well as in
the treatment of patients who are showing adverse effects from
already receiving an inappropriate implant.
Lessons from metal-on-metal THR implants have dem-
onstrated that the preference of the surgeon alone should not
be a driver in the determination of treatment for all patients.
Vast quantities of data are deposited in joint registries re-
garding the performance of different implants. These data,
coupled with the determination of immune tolerance to-
wards implant materials and biomarker studies to stratify
the heterogenic OA patient population, could pave the way
for a truly personalised approach to determining which
implant a specific patient should be given.
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